azurrx.com Report : Visit Site

Technical data of the azurrx.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host azurrx.com. Currently, hosted in United States and its service provider is OCS Solutions Inc. .

the related websites

hl.co.uk uk.investing.com pipelinereview.com evolutionexec.com uk.advfn.com businessresearchstore.com uk.webfg.com barchart.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

nasdaq: azrx search sign up about back president's message board of directors the team science & technology back overview programs development pipeline cystic fibrosis chronic pancreatitis nosocomial infections non-systemic biologics digestive enzymes antibiotics and the gut investors back press releases back 2018 2017 2016 2015 2014 events back upcoming events past events regulatory filings financial statements back 2018 back q1 2018 2017 back q4 2017 q3 2017 q2 2017 q1 2017 2016 back q4 2016 q3 2016 stock info analyst coverage corporate governance contact us clinical studies back completed clinical studies clinical publications collaborations back partnering with azurrx contact back contact us subscribe welcome to azurrx about us azurrx biopharma is a development stage biopharmaceutical company (nasdaq: azrx) focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. our therapeutic products will be administered to patients as oral non-systemic biologics. the company currently has two products in its pipeline: ms1819 , a recombinant lipase for the treatment of exocrine pancreatic insufficiency (for cystic fibrosis and chronic pancreatitis patients) and azx1101 , a recombinant enzyme for the prevention of hospital-acquired c. difficile infections. the company is headquartered in new york city, with scientific operations in langlade, france. latest news azurrx announces appointment of dr. james pennington as chief medical officer may 30 2018 read more ... azurrx biopharma announces pricing of $10.4 million public offering of common stock may 01 2018 read more ... azurrx biopharma announces proposed public offering of common stock apr 30 2018 read more ... read all the latest news stock quote azrx *delayed quote courtesy of google. corporate presentation click here to download 2018 annual general meeting click here for associated documents fact sheet click here for associated documents about science & technology investors clinical studies collaborations contact contact us azurrx biopharma, inc. 760 parkside avenue downstate biotechnology incubator suite 304 brooklyn, ny 11226 tel: 646-699-7855 [email protected] azurrx sas jardin des entreprises, bat 1 290, chemin de saint-dionisy 30980 langlade, france tel: +33 (0)4 66 67 08 16 ⓒ 2018 azurrx all rights reserved. website by sandman media inc.

URL analysis for azurrx.com

http://azurrx.com/index.php/investors/stock-info
http://azurrx.com/index.php/investors/financial-statements/2018/q1-2018
http://azurrx.com/index.php/investors/financial-statements/2016/q4-2016
http://azurrx.com/index.php/news-feed?format=feed&type=rss
http://azurrx.com/index.php/investors/financial-statements/2017/q3-2017
http://azurrx.com/index.php/about/the-team
http://azurrx.com/index.php/contact/subscribe?view=form
http://azurrx.com/index.php/science-technology/cystic-fibrosis
http://azurrx.com/index.php/investors/press-releases/2014
http://azurrx.com/index.php/investors/press-releases/2015
http://azurrx.com/index.php/investors/press-releases/2016
http://azurrx.com/index.php/investors/press-releases/2017
http://azurrx.com/index.php/investors/financial-statements/2017/q2-2017
http://azurrx.com/index.php/science-technology/chronic-pancreatitis
http://azurrx.com/index.php/about/board-of-directors

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: AZURRX.COM
Registry Domain ID: 1854597085_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2014-04-14T02:13:30Z
Creation Date: 2014-04-14T02:13:30Z
Registry Expiry Date: 2019-04-14T02:13:30Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS19.DOMAINCONTROL.COM
Name Server: NS20.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-23T03:23:55Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR GoDaddy.com, LLC

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =azurrx.com

  PORT 43

  TYPE domain

DOMAIN

  NAME azurrx.com

  CHANGED 2014-04-14

  CREATED 2014-04-14

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientRenewProhibited https://icann.org/epp#clientRenewProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS19.DOMAINCONTROL.COM 216.69.185.10

  NS20.DOMAINCONTROL.COM 173.201.77.10

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .